NEW

FDA Updates Information on Respirator Decontamination Systems

The U.S. Food and Drug Administration (FDA) is reissuing the Emergency Use Authorizations for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological...

First Patient Treated in Clinical Trial of BCL System

CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, announced that the first patient has been treated in its U.S. pivotal trial of the Breast Cancer Locator (BCL) System at Massachusetts General Hospital.

Rush Oak Park Hospital Adopts Surgical Workflow Technology, ExplORer Surgical, Increasing Team Confidence and Reducing OR Challenges

ExplORer Surgical, the only comprehensive intraoperative case support and workflow platform, has reinvented the way surgical support teams prepare and complete effective surgeries with two-way video for case support and remote proctoring to create a digitized playbook.

AORN Releases 2021 Guidelines for Perioperative Practice

The Association of periOperative Registered Nurses (AORN) has published the 2021 Guidelines for Perioperative Practice with six revised guidelines.

FIRST PATIENTS TREATED IN NEW ROBOTIC ARRHYTHMIA CARE PROGRAM AT OVERLAND PARK REGIONAL MEDICAL CENTER

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that HCA Midwest Health—the largest healthcare system in the Kansas City region—has launched a new robotic arrhythmia care program based at Overland Park Regional Medical Center (OPRMC). Installation of the Stereotaxis Robotic Magnetic Navigation (RMN) System was recently completed, and the first patients have been successfully treated using the technology at Overland Park Regional Medical Center.

Stereotaxis’ partnership with HCA Midwest Health brings new, leading-edge treatment options for patients who have a cardiac arrhythmia. The addition of RMN is a key component of the cardiology program at OPRMC and HCA Midwest Health, allowing for patient-focused clinical and technological leadership as well as enabling the providers and clinical team to better address a range of complex arrhythmias that otherwise might not have been treatable.

RMN uses robotics and magnetic fields to navigate a cardiac catheter directly from the tip. The technology consists of two robotically controlled magnets placed next to the operating table. During the procedure, a physician uses a computer interface to adjust the magnetic field around the patient and precisely direct and steer this cardiac ablation catheter in the heart.

Dr. Dhanunjaya “DJ” Lakkireddy, Medical Director, Kansas City Heart Rhythm Institute at HCA Midwest Health and a partner of Midwest Heart and Vascular Specialists, has been at the forefront of this technological innovation. Dr. Lakkireddy was instrumental in authoring the meta-analysis published in the Journal of Interventional Cardiac Electrophysiology (September 2017). The study emphasized the clinical value of robotics for the treatment of arrhythmias.

“The new cardiac arrhythmia labs at OPRMC were recently opened and are currently treating patients,” said Dr. Lakkireddy. “They represent the latest advances in the field of electrophysiology including robotic technology that enables improved outcomes and unparalleled safety for patients during cardiac ablation procedures. Robotics also allows OPRMC electrophysiologists to better address a range of complex arrhythmias that otherwise might not have been treated, providing hope to many patients who otherwise would have had no options for cardiac arrhythmia. We have observed the clinical value of robotic cardiac ablation and are excited to be providing patients convenient access to this technology.”

“As a world-renowned leader in electrophysiology research and patient care, Dr. Lakkireddy recognizes the significant patient, provider, and physician benefits of RMN. Stereotaxis technology affords OPRMC increased capabilities and a new and novel way to treat patients with cardiac arrhythmias,” explained David Fischel, Chairman and Chief Executive Officer of Stereotaxis. “We look forward to supporting the Kansas City Heart Rhythm Institute and HCA Midwest Health as they improve patient care, advance clinical science, and grow a highly successful robotic arrhythmia care practice in Kansas City.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X